Patents by Inventor Abdolsamad Tadayon

Abdolsamad Tadayon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRYSTAL FORM OF 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL
    Publication number: 20080132554
    Abstract: The present invention is directed to an anhydrate crystal form (Form D) of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol, an estrogenic receptor modulator useful in the treatment of, for example, diseases related to abnormal levels of estrogen.
    Type: Application
    Filed: November 20, 2007
    Publication date: June 5, 2008
    Applicant: WYETH
    Inventors: Abdolsamad TADAYON, Silvio IERA, Mahmoud MIRMEHRABI
  • Crystal forms of (S)-(8(2,6-dichlorophenyl)-6-fluoro-2,3-dihydro benzo[b][1,4]dioxin-2-yl)methanamine hydrochloride salt
    Publication number: 20070249709
    Abstract: The present invention is directed to crystal forms of the 5-HT2C agonist (S)-(8-(2,6-dichlorophenyl)-6-fluoro-2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methanamine hydrochloride, as well as compositions, processes of preparation, and uses thereof.
    Type: Application
    Filed: April 17, 2007
    Publication date: October 25, 2007
    Applicant: Wyeth
    Inventors: Mahmoud Mirmehrabi, Qing Yu, Abdolsamad Tadayon, Marc Tesconi, Yan Xu
  • Crystalline and amorphous 4-cyano-N-{(2R)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin -1-yl]-propyl}-N-pyridin-2-yl-benzamide hydrochloride
    Publication number: 20070027162
    Abstract: The present invention is directed to crystal and amorphous forms of the 5-HT1A receptor antagonist 4-cyano-N-{(2R)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin-1-yl]-propyl}-N-pyridin-2-yl-benzamide hydrochloride, as well as compositions thereof and methods of using the same.
    Type: Application
    Filed: February 27, 2006
    Publication date: February 1, 2007
    Applicant: Wyeth
    Inventors: Eric Browne, Michel Bernatchez, Mark Lankau, Abdolsamad Tadayon, Anthony Hadfield
  • Crystal forms of {[(2r)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride
    Publication number: 20060252825
    Abstract: The present invention is directed to crystalline forms of the 5-HT2C agonist {[(2R)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride, as well as compositions, processes of preparation, and uses thereof.
    Type: Application
    Filed: April 21, 2006
    Publication date: November 9, 2006
    Applicant: Wyeth
    Inventors: Abdolsamad Tadayon, Qing Yu, Michel Bernatchez
  • Quinoxaline dihydrohalide dihydrates and synthetic methods therefor
    Publication number: 20060211699
    Abstract: Crystalline polymorph forms of Gonadotropin Releasing Hormone receptor antagonists, including crystalline polymorphs of quinoxaline dihydrohalide dihydrates, in particular crystalline polymorphs of 6-({4-[2-(4-tert-butylphenyl)-1H-benzimidazol-4-yl]-piperazin-1-yl}methyl)-quinoxaline dihydrochloride dihydrate, methods of making the same, as well as pharmaceutical compositions, and dosage forms containing them are disclosed.
    Type: Application
    Filed: March 7, 2006
    Publication date: September 21, 2006
    Applicant: Wyeth
    Inventors: Silvio Iera, Abdolsamad Tadayon, John Sellstedt, Subodh Deshmukh
  • Crystal forms of 2-(3-Fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazole-5-ol
    Publication number: 20060205798
    Abstract: The present invention is directed to monohydrate and anhydrate crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol, an estrogenic receptor modulator useful in the treatment of, for example, diseases related to abnormal levels of estrogen.
    Type: Application
    Filed: March 6, 2006
    Publication date: September 14, 2006
    Applicant: Wyeth
    Inventors: Abdolsamad Tadayon, Silvio Iera, Hong Wen, Marc Tesconi, Mannching Ku
  • 3-({4-[2-(4-Tert-butylphenyl)-1h-benzimidazol-4-yl]piperazin-1-yl}methyl)pyrido[2,3-b]]pyrazi ne compounds
    Publication number: 20060189619
    Abstract: The present invention relates to Gonadotropin Releasing Hormone (“GnRH”) (also known as Leutinizing Hormone Releasing Hormone) receptor antagonists.
    Type: Application
    Filed: February 24, 2006
    Publication date: August 24, 2006
    Applicant: WYETH
    Inventors: Abdolsamad Tadayon, Jacqueline Lunetta, Kiomars Karami, Zheng Wang
  • Crystalline polymorphs of (3S)-N-hydroxy-4-({4-[(4-hydroxy-2-butynul)oxy]phenyl}sulfonyl)-2,2-dimethyl-3-thiomorpholine carboxamide
    Publication number: 20050272929
    Abstract: This invention relates to crystalline polymorphs of (3S)-N-hydroxy4-({4-[(4-hydroxy-2-butynyl)oxy]phenyl}sulfonyl)-2,2-dimethyl-3-thiomorpholine carboxamide, and preparation and uses thereof.
    Type: Application
    Filed: June 7, 2005
    Publication date: December 8, 2005
    Applicant: Wyeth
    Inventors: Wei Tong, Abdolsamad Tadayon, Peter Larkin, Lalitha Krishnan, Subodh Deshmukh, Jean Akin